APT(SH:688617) Sou Hu Cai Jing·2025-08-11 12:20Group 1 - The core viewpoint of the news is that Huatai Medical's stock has shown a recent increase, with a closing price of 298.0 yuan, up 3.37%, and a rolling PE ratio of 58.68, marking a new low in 23 days [1] - The total market capitalization of Huatai Medical is 42.022 billion yuan, and it ranks 89th in the medical device industry based on PE ratio, which has an average of 56.56 and a median of 39.76 [1] - As of the first quarter of 2025, 110 institutions hold shares in Huatai Medical, with a total of 18.3304 million shares valued at 5.444 billion yuan [1] Group 2 - Huatai Medical specializes in the research, production, and sales of electrophysiological and interventional medical devices, with key products including electrophysiological, coronary access, peripheral vascular interventional, and non-vascular interventional devices [1] - The latest financial results for the first quarter of 2025 show that the company achieved a revenue of 564 million yuan, representing a year-on-year increase of 23.93%, and a net profit of 183 million yuan, reflecting a year-on-year growth of 30.69%, with a gross profit margin of 73.09% [1]